Association of Activating KIR Copy Number Variation of NK Cells with Containment of SIV Replication in Rhesus Monkeys by Hellmann, Ina et al.
Association of Activating KIR Copy Number Variation of
NK Cells with Containment of SIV Replication in Rhesus
Monkeys
Ina Hellmann
1, So-Yon Lim
1, Rebecca S. Gelman
2, Norman L. Letvin
1*
1Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America, 2Department of
Biostatistics, Dana Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States of America
Abstract
While the contribution of CD8
+ cytotoxic T lymphocytes to early containment of HIV-1 spread is well established, a role for
NK cells in controlling HIV-1 replication during primary infection has been uncertain. The highly polymorphic family of KIR
molecules expressed on NK cells can inhibit or activate these effector cells and might therefore modulate their activity
against HIV-1-infected cells. In the present study, we investigated copy number variation in KIR3DH loci encoding the only
activating KIR receptor family in rhesus monkeys and its effect on simian immunodeficiency virus (SIV) replication during
primary infection in rhesus monkeys. We observed an association between copy numbers of KIR3DH genes and control of
SIV replication in Mamu-A*01
– rhesus monkeys that express restrictive TRIM5 alleles. These findings provide further evidence
for an association between NK cells and the early containment of SIV replication, and underscore the potential importance
of activating KIRs in stimulating NK cell responses to control SIV spread.
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Introduction
Natural killer (NK) cells are the primary effector cells of the
innate immune system, representing a first line of defense against
viruses through their ability to lyse virally infected cells without
prior antigen sensitization [1–3]. NK cells express a complicated
set of activating and inhibitory receptors on their cell surfaces that
recognize specific ligands on target cells [4]. Inhibitory receptors
transmit inhibitory signals to NK cells that protect healthy cells
from destruction by NK cell-mediated cytotoxicity, whereas
activating NK cell receptors transmit activating signals to these
effector cells. It is the balance of these opposing signals that
determines the activation state of an NK cell and, in so doing,
regulates NK cell-mediated killing and cytokine production [5–7].
Among these receptor families expressed by NK cells are the
inhibitory and activating killer cell immunoglobulin-like receptors
(KIR). The highly polymorphic KIRs recognize MHC class I
molecules as ligands [8,9], and the coincident expression of certain
KIRs and MHC class I molecules in an individual influences the
outcome of a number of viral infections [10,11].
Recent studies have shown that activating KIRs and their MHC
class I ligands can affect AIDS pathogenesis. The expression of
KIR3DS1, an activating KIR receptor, has been shown to delay
AIDS progression when its ligand, HLA-B Bw4 alleles with an
isoleucine at position 80 (HLA-B Bw4-80Ile), is coexpressed in an
individual [12]. Consistent with this finding, an in vitro functional
analysis showed that KIR3DS1
+ NK cells are able to inhibit HIV-
1 replication in HLA-B Bw4-80Ile
+ target cells [13]. Further,
KIR3DS1
+ NK cells selectively expand during acute HIV-1
infection in the presence of HLA-B Bw4-80Ile [14]. In addition to
these findings, others have reported an association between the
expression of certain inhibitory KIR3DL1 allotypes and protection
against HIV-1 disease progression, when the KIR3DL1 ligand,
HLA-B Bw4 alleles, is also expressed in an individual [15].
Studies of the contributions of NK cells to HIV-1 control have
been limited by the difficulties associated with finding individuals
who can be evaluated during the earliest phase of the infection. The
SIV-infected rhesus monkey therefore provides a critical model for
exploring NK cell biology in the setting of an AIDS virus infection
[16]. We have previously shown that there are five KIR receptor
families in rhesus monkeys [17]. KIR3DH is the only activating
KIR family in this nonhuman primate species, and this family of
molecules is highly polymorphic [18–21]. An understanding of this
KIR gene family of rhesus monkeys provides an important basis for
exploring the contributions of KIR receptors and NK cells in early
AIDS pathogenesis in the SIV/macaque model. In the present
study, we evaluated the copy number variation (CNV) of activating
KIRs in rhesus monkeys and demonstrated an association between
the extent of this CNV and SIV control during primary SIV
infection in a cohort of Mamu-A*01
– rhesus monkeys that were
homozygous for the restrictive TRIM5 alleles.
Results
Establishment and validation of a qPCR assay to
determine KIR3DH CNV
This study was initiated to explore the copy number variation of
activating KIR genes of Indian-origin rhesus monkeys and its
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phase of SIV infection. To date, only one activating KIR receptor
family, KIR3DH, also termed KIR3DS in recent publications to
be consistent with the nomenclature used in describing human
KIRs [19,21], has been identified in rhesus monkeys. Interestingly,
the KIR3DH receptor family in this macaque species comprises
genes that display extensive polymorphism. To determine the copy
number of activating KIR genes in rhesus monkeys, we developed
a quantitative real-time PCR assay (qPCR) using a primer/probe
set that binds to a conserved region of KIR3DH genes that encodes
the transmembrane domain of the KIR3DH proteins. This
primer/probe set was designed to amplify 23 previously described
KIR3DH alleles (GenBank accession numbers MmKIR3DH1-4
(AF334648-AF334651), MmKIR3DH7-21 (EU702453-EU702473),
MmKIR3DH-like1-4 (AY505479-82)) [17,18]. We confirmed that
this primer/probe set does not bind inhibitory KIR genes by
sequencing the qPCR amplicons (data not shown).
Genomic DNA derived from B-lymphoblastoid cell lines
(B-LCLs) or peripheral blood mononuclear cells (PBMCs) of 77
rhesus monkeys was extracted, and KIR3DH copy numbers were
determined for each monkey by qPCR using serial dilutions of a
plasmid containing the amplicon of the KIR3DH qPCR reaction.
STAT6, since it is present at two copies per diploid genome (pdg),
was used as a reference gene in these studies [22]. Intra-
experimental reproducibility of the qPCR assay was confirmed
by analyzing triplicate samples for each of the 77 monkeys in two
separate experiments, determining KIR3DH copy numbers based
on the means of the triplicate values (R
2 = 0.866, b = 0.816)
(Figure 1A).
To validate the accuracy of the KIR3DH copy number qPCR
assay, we developed a multiplex ligation-dependent probe
amplification assay (MLPA). Twenty genomic DNA samples were
analyzed using one oligonucleotide set for the KIR3DH genes and,
for reference genes, two oligonucleotide sets for EP300 encoding
the E1A binding protein p300 and one set for CREBBP encoding
the CREB-binding protein. EP300 and CREBBP are each present
at two copies pdg in the rhesus monkey genome. Because of the
extensive polymorphism at the KIR3DH loci, only one MLPA
oligonucleotide set could be designed that bound to the same
KIR3DH genes amplified in the qPCR assay. Relative MLPA
signals for KIR3DH, normalized against the control gene signals,
were assessed in two MLPA experiments using the same DNA
samples. These signals clustered into groups corresponding to copy
numbers 2, 3, 4 and 5 (Figure 1B). The KIR3DH copy
numbers determined by MLPA were correlated with KIR3DH
copy numbers determined by qPCR (R
2 = 0.77, b = 0.729)
(Figure 1C).
KIR3DH copy numbers vary extensively in Indian-origin
rhesus monkeys
Using this assay, we determined KIR3DH copy numbers in a
cohort of 77 Indian-origin rhesus monkeys (Figure 2A). KIR3DH
copy numbers varied extensively in this cohort of monkeys,
ranging from 0 to 12 copies pdg (median = 4.11 copies pdg). We
rejected that this distribution had a Gaussian distribution by the
skewness test (P = 0.001; i.e., the distribution was not symmetric)
as well as by the kurtosis test (P = 0.005; i.e., the distribution is
more sharply peaked than the Gaussian), the chi-squared test (P =
0.0006), and the Shapiro-Wilks test (P = 0.003) (data not shown).
Since the aim of this study was to determine the association of
activating KIR copy numbers on early control of SIV replication,
we first sought to determine whether activating KIR copy
numbers in this species co-stratified with other alleles already
implicated in SIV control. Therefore, we assessed whether
KIR3DH copy numbers in this cohort of animals were associated
with their Mamu-A*01 or Mamu-B*17 status or their expression of
particular TRIM5 alleles. The expression of certain MHC class I
Author Summary
NK cells are effector cells of the innate immune system
that contribute to protection against virus infections
through their ability to lyse virus-infected cells without
prior antigen sensitization. Their role in controlling HIV-1
replication during primary infection has been uncertain.
NK cell activation is regulated by inhibitory and activating
KIRs that recognize MHC class I molecules expressed by
target cells. In the present study, we identify an association
between the copy number of activating KIR genes in
rhesus monkeys and the control of SIV replication during
primary infection in Mamu-A*01
– rhesus monkeys that
express restrictive TRIM5 alleles. This observation under-
scores the potential importance of activated NK cells in the
control of SIV spread during the early stages of infection.
Figure 1. Intra-run reproducibility in KIR3DH copy number determination and validation of quantitative real-time PCR estimates of
KIR3DH copy numbers by MLPA (multiplex ligation-dependent probe amplification). (A) KIR3DH copy numbers were determined using
triplicates of each DNA sample from 77 rhesus monkeys in two separate experiments to validate intra-experiment reproducibility (R
2 = 0.87, b =
0.816). (B) Comparison of signal ratios of two MLPA experiments. Pairs of ratios (20 samples) cluster around groups corresponding to KIR3DH copy
numbers of 2, 3, 4 and 5. (C) Relationship between KIR3DH copy numbers determined by qPCR and MLPA (R
2 = 0.77, b = 0.729). The 95% confidence
interval is shown by dashed lines.
doi:10.1371/journal.ppat.1002436.g001
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associated with control of virus replication and delayed disease
progression following SIV infection of Indian-origin rhesus
monkeys [23–27]. We have also recently demonstrated the role
of rhesus monkey TRIM5 alleles 1–5 in restricting SIV infection
and the impact of this restriction on the clinical outcome of SIV
infection in vivo [28]. Although MHC class I, TRIM5 and KIR3DH
genes are encoded on different chromosomes in rhesus monkeys,
contributions to SIV control by one allele could be a surrogate for
the effects of another allele, as seen for CCL3L and Mamu-A*01
[29]. We found that KIR3DH copy numbers were not significantly
different between Mamu-A*01
+ and Mamu-A*01
– rhesus monkeys
(Mann-Whitney, P = 0.31) (Figure 2B). Moreover, KIR3DH copy
numbers were also not significantly different between Mamu-B*17
–
and Mamu-B*17
+ monkeys (Mann-Whitney, P = 0.49). There
were insufficient Mamu-B*08
+ animals (n=3) in this cohort to
assess the associations of this allele with KIR3DH copy numbers.
Finally, we found that KIR3DH copy numbers were not
significantly different in rhesus monkeys expressing only TRIM5
alleles 1–5 and rhesus monkeys expressing at least one of the
permissive TRIM5 alleles 6–11 (Mann-Whitney, P = 0.75), nor
were they significantly different when considering the four subsets
of Mamu-A*01 and TRIM5 (Kruskal-Wallis, P = 0.19).
High KIR3DH copy numbers are associated with lower
peak SIV RNA levels in Mamu-A*01
– rhesus monkeys
To explore whether copy number variation of activating
KIR3DH alleles in rhesus monkeys might be associated with
protection against SIV replication, we evaluated a cohort of 57
rhesus monkeys infected with SIVmac251. SIV plasma RNA levels
were measured in these monkeys at peak and set-point of the
infection, days 14 and 70 post-SIV challenge, respectively, since
these measures of viremia have been shown to be predictors of SIV
disease progression in rhesus monkeys [30,31]. No association of
KIR3DH copy numbers and viral load at peak (Figure 3A) or set-
point (data not shown) was observed. To explore further a possible
relationship between activating KIR copy numbers and control of
SIV replication in vivo, we divided this cohort of rhesus monkeys
into two groups based on their expression or lack of expression of
the MHC class I allele Mamu-A*01. Since its expression can
Figure 2. Distribution of KIR3DH copy numbers in Indian-origin rhesus monkeys. Copy numbers of KIR3DH genes were determined using
quantitative real-time PCR on genomic DNA of 77 Indian-origin rhesus monkeys. (A) Distribution of KIR3DH copy numbers in the entire cohort of
monkeys. (B) Boxplots of KIR3DH copy number distribution in rhesus monkeys divided into three cohorts: Mamu-A*01
– and Mamu-A*01
+ rhesus
monkeys, Mamu-B*17
– and Mamu-B*17
+ rhesus monkeys and rhesus monkeys expressing only TRIM5 alleles 1–5 or expressing at least one TRIM5
allele from the group 6–11. (C) The median, mean and standard deviation (SD) of KIR3DH copy numbers are shown for various subgroups of rhesus
monkeys. P values were calculated using the Mann-Whitney U test (two-tailed).
doi:10.1371/journal.ppat.1002436.g002
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Mamu-A*01 might mask effects of other host alleles on controlling
viral replication during SIV infection. On the basis of similar
reasoning, the Mamu-A*01
+ and Mamu-A*01
– rhesus monkeys
were further divided into monkeys expressing only the TRIM5
alleles 1–5 and monkeys expressing at least one TRIM5 allele from
the group 6–11. Finally, the monkeys were further subdivided into
those having KIR3DH copy numbers above the median ($4.111
copies pdg) and those having KIR3DH copy numbers below the
median (,4.111 copies pdg). As expected, the Mamu-A*01
+
monkeys had lower viral load values at peak and set-point than the
Mamu-A*01
– monkeys (data not shown). In Mamu-A*01
+ rhesus
monkeys, even when those monkeys were divided according to
their TRIM5 allele expression, there was no association between
KIR3DH copy numbers and peak (Figure 3B) or set-point (data not
shown) viral load. However, there were too few monkeys with
TRIM5 alleles 1–5 to determine whether there was such an
association. Strikingly, in the Mamu-A*01
– rhesus monkeys, we
observed a very strong negative trend toward an association
between KIR3DH copy numbers and peak plasma SIV RNA levels
(P = 0.08) (Figure 3C). The association between KIR3DH copy
numbers and peak plasma SIV RNA levels was even more
pronounced in Mamu-A*01
– rhesus monkeys expressing only the
TRIM5 alleles 1–5. In this group of monkeys, animals having
KIR3DH copy numbers above the median had significantly lower
peak SIV RNA levels than animals having KIR3DH copy numbers
below the median (Mann-Whitney, P = 0.02), with a 0.4 log
median difference. We also analyzed the association between
KIR3DH copy number and peak plasma viral load by fitting the
data to a parabola or a linear spline with a fixed knot at a KIR3DH
copy number of 5. The fixed knot of 5 was chosen because of
previous reports that an individual NK cell usually expresses 3–5
KIRs that are randomly selected on their surface [32]. We
hypothesized that KIR3DH copy numbers above 5 might not be
associated with a linear increase in surface expression of KIR3DH
molecules. In the Mamu-A*01
–, TRIM5 1–5 expressing monkeys,
we observed comparable significance for the coefficient of the
linear term in the parabola and for the slope of the spline for copy
number #5 (P=0.015 and P=0.016), the squared term in the
parabola and the slope of the second spline were not significant
(P=0.074 and P=0.53) (Supplementary Figure S2 in Text S1).
Interestingly, this association was no longer apparent by the time
viral set-point was reached on day 70 post-infection (data not
shown). These results suggest that NK cells from this subset of
monkeys expressing higher numbers of KIR3DH copies may
contribute more to control of SIV replication than NK cells from
monkeys expressing lower numbers of activating KIR copies.
KIR3DH CNV is not associated with other clinical sequelae
of SIV infection
We then assessed some of the clinical consequences of SIV
infection in Mamu-A*01
– rhesus monkeys. The loss of peripheral
Figure 3. Association of KIR3DH copy numbers and peak plasma SIV RNA levels in Indian-origin rhesus monkeys. KIR3DH copy
numbers were determined by quantitative real-time PCR using genomic DNA from rhesus monkeys. Peak plasma SIV RNA levels were quantified on
day 14 post-SIVmac251-infection. Scatter plots represent the relationship between SIV peak viral load and KIR3DH copy numbers in the entire cohort
of rhesus monkeys (P = 0.70) (A), in Mamu-A*01
+ rhesus monkeys (P = 0.24) (B) and in Mamu-A*01
– rhesus monkeys (P = 0.08) (C). The Mamu-A*01
+
and Mamu-A*01
– rhesus monkeys were subdivided into two groups: one group having KIR3DH copy numbers below the median (black) and the other
group having KIR3DH copy numbers above the median (blue). These groups were further subdivided into monkeys expressing only TRIM5 alleles 1–5
or expressing at least one TRIM5 allele of the group 6–11. P values were determined using the Mann-Whitney U test (two-tailed).
doi:10.1371/journal.ppat.1002436.g003
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+ T cells, and more importantly, central memory (CM)
CD4
+ T cells following SIV infection have been shown to predict
survival of the infected rhesus monkeys [31]. Therefore, we
evaluated the loss of peripheral blood CD4
+ T cells and central
memory (CM) CD4
+ T cells on days 14 (peak) and 70 (set-point)
following SIVmac251 infection in these monkeys. Data were
assessed by dividing the Mamu-A*01
– rhesus monkeys into those
having KIR3DH copy numbers above the median ($4.11 copies
pdg) and those having KIR3DH copy numbers below the median
(,4.11 copies pdg). Neither loss of total CD4
+ T cells nor loss of
CM CD4
+ T cells was significantly associated with KIR3DH copy
numbers in these monkeys (Figure 4A, B). We also evaluated
survival as a clinical indicator of long-term protection following
SIV infection in the Mamu-A*01
– rhesus monkeys. Assessing the
percentage of monkeys that had died by day 283 following SIV
infection (day 283 was chosen ahead of time; after 283 days some
monkeys were euthanized and some monkeys were used in other
experiments), we observed no association between KIR3DH copy
numbers and survival following infection (data not shown).
Therefore, peak viral load was the only clinical correlate of
KIR3DH copy numbers in this cohort of monkeys.
KIR3DH CNV is not associated with the expression of
particular KIR3DH alleles
Since some reports by other investigators had suggested that
particular KIR alleles were associated with high plasma viral RNA
levels in SIV-infected rhesus monkeys [20,33], we investigated
whether particular KIR3DH alleles contributed to the association
between KIR3DH copy numbers and control of peak SIV RNA
levels in these monkeys. Full-length KIR3DH cDNA clones
generated from 8 unrelated, Mamu-A*01
– rhesus monkeys with
different KIR3DH copy numbers ranging from 1–10 copies pdg
were acquired by PCR. Two of the isolated KIR cDNA sequences
were identical to rhesus monkey KIR alleles that had previously
been reported (Mamu-KIR3DS10-JHB-HQ (GU112262) and
Mamu-KIR3DS05-JHB-HH (GU112301)) [19]. The majority of
isolated KIR cDNA clones differed in their sequences from
previously reported rhesus monkey KIR sequences. These novel
sequences have been assigned the GenBank accession numbers
JN613291-JN613300. The predicted amino acid sequences of all
KIR3DH alleles were aligned (Supplementary Figure S1 in Text
S1). While some KIR3DH cDNA sequences were only observed in
individual monkeys (eg. JN613291), other KIR3DH alleles were
observed in multiple monkeys (eg. JN613292) (Figure 5). Impor-
tantly, there was no apparent trend toward certain KIR3DH alleles
being expressed in rhesus monkeys with low or high KIR3DH copy
numbers. Therefore, there was no evidence that a particular
KIR3DH allele was responsible for the observed effect on early SIV
control.
Higher KIR3DH copy numbers associate with high and
stable KIR3DH transcript levels
To assess how activating KIR CNV might affect early SIV
containment, we first determined the association between the
number of KIR3DH copies in a cell and the expression of KIR3DH
genes by that cell. We utilized the qPCR assay that we developed
for determining KIR3DH CNV to measure KIR3DH mRNA
expression levels in peripheral blood CD16
+ NK cells of 28 naı ¨ve
rhesus monkeys. Relative KIR3DH mRNA expression was sig-
nificantly associated with KIR3DH copy numbers in the evaluated
cell populations, as determined by linear regression analysis
(P = ,0.001, R
2 = 0.51) (Figure 6A). To determine if these
differences in KIR3DH RNA expression levels persisted over time,
we sampled 15 of these naı ¨ve rhesus monkeys one month later,
and KIR3DH RNA expression levels at both sampling dates were
measured in the same qRT-PCR run. Relative mRNA expression
levels of KIR3DH genes from the first and second sampling
associated positively, reaching statistical significance as determined
by linear regression analysis (P = 0.03, R
2 = 0.33) (Figure 6B).
These findings suggest that increased KIR3DH copy numbers
associate with high, stable KIR3DH mRNA expression levels.
KIR3DH CNV and NK cell frequencies on day 28 following
SIV infection
We next investigated the relative representation of various
subpopulations of NK cells in rhesus monkeys expressing different
numbers of KIR3DH copies. Rhesus monkey NK cells were
defined as CD3
– CD8a
+ NKG2A
+, and CD16 and CD56
expression were used to delineate three NK cell subsets: CD16
+,
Figure 4. Lack of association between KIR3DH copy numbers and clinical course following SIVmac251 infection in Mamu-A*01
–
rhesus monkeys. Peripheral blood CD4
+ T cell and central memory (CM) CD4
+ T cell counts were measured by flow cytometry and complete blood
counting. Loss of CD4
+ T cells (A) and CM CD4
+ T cells (B) were determined on days 14 and 70 post-challenge (pc). The Mamu-A*01
– rhesus monkeys
were divided into two groups: monkeys having KIR3DH copy numbers below (black) or above (blue) the median.
doi:10.1371/journal.ppat.1002436.g004
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+ and double-negative (DN) NK cells (Figure 7A). Since
these subsets have been previously shown to mediate different
effector functions, an expansion or contraction might only be
expected to occur in certain NK cell subsets. The relative
representation of NK cells, as a percentage of total circulating
lymphocytes, and of NK cell subsets, as a percentage of total NK
cells, were determined by flow cytometric analysis of PBMCs of
naı ¨ve monkeys and of monkeys sampled on day 28 following
SIVmac251 infection (Figure 7B). Data were displayed by
grouping the monkeys into those having KIR3DH copy numbers
below and those having KIR3DH copy numbers above the median.
In the naı ¨ve rhesus monkeys, the relative representation of
circulating NK cells did not associate with differences in KIR3DH
copy numbers. We observed a modest increase in the relative
representation of NK cells in monkeys harboring a greater number
of KIR3DH copies than the median on day 28 post-SIVmac251
infection (median, 9.27%; range, 2.15–15.82%; n=9) compared
to monkeys having KIR3DH copy numbers below the median
Figure 6. KIR3DH mRNA expression is associated with KIR3DH copy numbers in CD14
–CD16
+ NK cells. CD14
–CD16
+ NK cells were isolated
from PBMCs of naı ¨ve rhesus monkeys using immunomagnetic beads. RNA was extracted from these isolated cells and KIR3DH mRNA expression levels
were determined by quantitative RT-PCR. Relative RNA expression was calculated using the 2
2DDCP method. (A) Scatter plots show the association
between KIR3DH copy numbers and KIR3DH mRNA expression levels (P = ,0.001, R
2 = 0.51). (B) KIR3DH mRNA expression levels were measured a
second time in the same animals after a one month interval (P = 0.03, R
2 = 0.33).
doi:10.1371/journal.ppat.1002436.g006
Figure 5. Expression of particular KIR3DH alleles is not associated with KIR3DH copy numbers. KIR3DH cDNA clones of 8 unrelated rhesus
monkeys with KIR3DH copy numbers ranging from 1–10 copies pdg were obtained using a PCR method described by Blokhuis et al. [18]. Two
previously reported KIR alleles (GU112262, GU112301) and ten novel KIR3DH alleles (JN613291-JN613300) were identified.
doi:10.1371/journal.ppat.1002436.g005
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difference in circulating NK cells did not reach statistical
significance (Mann-Whitney, P = 0.24). Since there is no available
antibody for staining KIR3DH molecules, NK cells that express
KIR3DH receptors on their surface can’t be distinguished from
those that do not.
Cytokine production of stimulated NK cell
subpopulations and expression of NK cell activation
molecules does not associate with KIR3DH CNV
We finally assessed some aspects of the functionality of NK cells
from rhesus monkeys harboring different copy numbers of
KIR3DH loci. We evaluated cytokine secretion by NK cells from
naı ¨ve and SIVmac251-infected monkeys in response to in vitro
stimulation. PBMCs were stimulated with K562 cells and the
intracellular expression of two cytokines produced by NK cells –
tumor necrosis factor a (TNFa) and interferon c (IFNc) – was
measured in the three primary NK cell subsets: CD16
+, CD56
+
and DN NK cells. As expected, the CD16
+ NK cells secreted little
cytokine [34], while the other NK cell subpopulations did secrete
cytokines upon stimulation (Figure 8). There was, however, no
obvious association between TNFa or IFNc secretion upon
stimulation and KIR3DH copy numbers by the CD56
+ and DN
NK cell subpopulations. This was seen in NK cells sampled from
both naı ¨ve and recently infected monkeys (Figure 8A, B and data
not shown).
We also assessed whether the surface expression of the
activation-associated molecules CD69, HLA-DR and NKp46 on
NK cell subsets was associated with KIR3DH copy numbers in
naı ¨ve rhesus monkeys and in the same cohort of monkeys at day
35 and at set-point following SIV infection. The intracellular levels
of the proliferation-associated Ki67 molecule in NK cells during
primary infection were also assessed. No association was observed
between KIR3DH copy number and the expression of these
molecules in CD16
+, DN or CD56
+ NK cells pre- or post-infection
(Supplementary Figure S3 in Text S1 and data not shown).
Discussion
The protective effects of particular KIRs for HIV-1 infections in
humans have, for the most part, been shown in epidemiologic
studies [12,35–37]. Functional studies of NK cells expressing
specific KIRs have been difficult to carry out in the early phases of
HIV-1 infections because the timing of HIV-1 acquisition cannot
be precisely determined from the clinical histories of patients. The
SIV-infected rhesus monkey therefore represents a potentially
important model for studying KIR receptors expressed on the
surface of NK cells and the effects of these cells on the control of
viral replication during primary infection. However, the ligands of
rhesus monkey KIRs are not well understood. The interaction
between a particular KIR and its ligand might, however, be
crucial for that KIR to modify disease outcome in HIV-1/SIV
infections. In fact, some reports suggest that associations between
particular KIR receptors and clinical sequelae of HIV-1 infections
are only observed when the ligands of those KIRs are considered
[12,36,38]. For example, coexpression of KIR3DS1 and its ligand
HLA-B Bw4-80Ile alleles was associated with a delayed progression
to AIDS in HIV-1-infected individuals, whereas the expression of
KIR3DS1 in the absence of the HLA-B Bw4-80Ile alleles was not
Figure 7. Distribution of peripheral blood NK cell subsets in Mamu-A*01
– rhesus monkeys. (A) Representative flow cytometric plots
defining NK cells. Rhesus monkey NK cells were defined as CD3
– CD8a
+ NKG2A
+, and CD16 and CD56 expression was used to delineate three primary
NK cell subsets: CD16
+, CD56
+ and double negative (DN) NK cells. (B) Percentages of circulating total NK cells as well as CD16
+, CD56
+ and double-
negative (DN) NK cells were compared in naı ¨ve rhesus monkeys and SIVmac251-infected rhesus monkeys on day 28 post-challenge. The rhesus
monkeys were divided into animals having KIR3DH copy numbers below (black) or above (blue) the median.
doi:10.1371/journal.ppat.1002436.g007
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infection [12]. In contrast to this observation, other studies in
humans have demonstrated that the expression of particular KIR
molecules was associated with a more favorable HIV-1 disease
outcome or decreased risk of HIV-1 acquisition irrespective of the
expression of the KIR ligands [37,39,40]. Also, studies of SIV-
infected rhesus monkeys showed that the expression of particular
inhibitory KIR3DL and KIR3DH molecules was associated with high
levelsofSIVreplicationwithoutconsiderationoftheligandsofthose
KIR molecules [20,33]. Consistent with the findings of these latter
studies, we observed an association between KIR3DH copy numbers
and peak SIV RNA levels during primary infection in monkeys that
did not express Mamu-A*01 and expressed the restrictive TRIM5
alleles 1-5 without considering the contribution of specific KIR
ligands. It is possible however, that the observed effect might be
more profound if KIR3DH ligands were taken into consideration.
The characterization of KIR3DH-expressing NK cell subpop-
ulations could be important for clarifying the role of activating
KIRs in modulating SIV replication. There is, however, no
monoclonal antibody that recognizes rhesus monkey KIR3DH,
and, therefore, surface expression of KIR3DH on monkey NK
cells cannot be monitored. Without such an antibody, NK cells
expressing high levels of KIR3DH molecules on their surface and
high frequencies of KIR3DH
+ NK cells cannot be distinguished.
In the present studies, we used KIR3DH RNA expression as a
surrogate for KIR3DH cell surface expression. The primer/probe
set used in the assay to quantify KIR3DH RNA expression binds to
a conserved region of the KIR3DH genes that encodes the
transmembrane domain of the KIR3DH proteins. Therefore,
truncated KIR proteins that have lost their transmembrane
domains due to frameshift deletions and are not anchored in the
cell membrane, as seen for allotypes of the human KIR2DS4 and
KIR2DL4 [41,42], would not be detected. We assume that higher
KIR3DH copy numbers, and the resulting higher KIR3DH
transcript levels, indicate an increased surface expression of
activating KIR receptors on subpopulations of NK cells.
The MHC class I allele Mamu-A*01 and TRIM5 alleles are
genetic determinants of the control of SIV replication in rhesus
monkeys [25,29,43]. A link was also reported between CCL3L
CNV and AIDS progression in SIV-infected rhesus monkeys [22].
We, however, showed that CCL3L CNV was serving as a surrogate
for the expression of Mamu-A*01, and the relatively benign clinical
course observed following SIV infection in certain monkeys was
actually a consequence of Mamu-A*01 expression by those animals
[29]. Because of these findings, it was important in the present
studies to show that KIR3DH copy numbers were not acting as a
surrogate marker for the Mamu-A*01 and TRIM5 status of the
monkeys. In our data, CNV of KIR3DH was not associated with
the expression of either Mamu-A*01, Mamu-B*17 or the restrictive
TRIM5 alleles. In addition, when Mamu-A*01 and TRIM5 were
both included in models, they did not eliminate the relationship of
KIR3DH copy number and peak viral load.
Figure 8. Secretion of tumor necrosis factor a (TNFa) in NK cell subsets following stimulation with K562 cells. PBMCs were stimulated
with K562 cells at an effector-to-target-ratio of 10:1. Percentages of TNFa
+ cells above background in CD16
+, CD56
+ and DN NK cells were measured
in peripheral blood of naı ¨ve rhesus monkeys (A) and SIVmac251-infected rhesus monkeys on day 28 post-challenge (B). For the day 28 post-challenge
timepoint, insufficient CD56
+ NK cells were acquired to allow an analysis.
doi:10.1371/journal.ppat.1002436.g008
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showed that KIR2DS2 copies ranged from 0 to 2 copies in humans
[38]. In that study, KIR2DS2 copy numbers were estimated using
KIR typing rather than single gene analysis. Pelak et al.
documented up to 3 copies of KIR3DS1 and 3 copies of KIR3DL1
in humans using a qPCR-based assay that was similar to the
quantitative assay we used in the present studies [Pelak et al.,
personal communication]. We, however, observed a wider range
of KIR3DH copies in rhesus monkeys with one monkey having 12
KIR3DH copies per cell. We defined copy numbers of the
KIR3DH family without evaluating individual KIR3DH genes.
These results are consistent with a recent study in rhesus monkeys
showing 0-4 KIR3DS genes per haplotype [19].
Both Gaudieri et al. and Pelak et al. investigated the effects of
copy number variation of KIR2DS2 and KIR3DS1 on HIV-1
disease outcome. Higher copy numbers of the activating KIR2DS2
were associated with greater CD4
+ T cell loss and rapid
progression to AIDS [38]. Since these investigators only indirectly
determined KIR2DS2 copy numbers and there is a strong linkage
disequilibrium between KIR2DS2 and KIR2DL2, the rapid HIV-1
disease progression in these individuals might not be attributable
to the expression of KIR2DS2. In the study by Pelak et al., higher
numbers of activating KIR3DS1 copies were associated with lower
plasma virus RNA levels at set-point in HIV-1 infected individuals
that express the KIR3DS1-ligand HLA-B Bw4-80Ile alleles [Pelak
et al., personal communication]. The findings in the present study
are in line with these observations.
The effect of activating KIR copy numbers on SIV replication
maybemoremodestthantheeffectsonSIVcontrolmediatedbythe
MHC class I molecule Mamu-A*01 and the restrictive TRIM5 alleles
[25,28,43]. Since the KIR3DH copy number effect was only seen in
the Mamu-A*01
– monkeys that were homozygous for restrictive
TRIM5alleles,itislikelythatastrongerMamu-A*01-associatedeffect
may obscure this NK cell contribution to SIV control. It is not
immediately obvious why the KIR3DH copy number effect was only
observed in the monkeys expressing the restrictive TRIM5 alleles.
In the present studies we showed that higher numbers of
KIR3DH copies were associated with lower peak viral load
following SIV infection, but we did not observe associations
between KIR3DH copy numbers and other clinical sequelae of
SIV infection. The contributions of NK cells to the control of SIV
replication may be manifested during the early stages of SIV
infection. Then, during the course of SIV-infection, virus-specific
CD8
+ T cells expand that maintain control over viral replication
throughout the chronic phase of infection [44–48]. The contribu-
tions of adaptive CD8
+ T cells to viral replication are likely much
greater than those mediated by NK cells, and these effects may
simply obscure those of KIR3DH-expressing NK cells on SIV
control during the later stages of infection. Further, the NK cells
may become too dysfunctional later in the course of infections to
mediate an antiviral effect [49–51].
Materials and Methods
Ethics statement
All of the animals used in this present study were Indian-origin
rhesus macaques. All monkeys were housed in accordance with the
guidelines of the NIH Guide for the Care and Use of Laboratory Animals and
withtheapprovalofthe InstitutionalAnimalCareandUseCommittee
of Harvard Medical School and the National Institutes of Health.
Animals and SIV infections
SIV-challenged monkeys were either infected intravenously or
intrarectally with an uncloned SIVmac251 inoculum [31]. The
expression of Mamu-A*01, Mamu-B*08, Mamu-B*17 and the
expression of TRIM5 alleles were assessed by PCR [28,29].
Plasma viral load assay and CD4
+ T lymphocyte counts
Plasma viral RNA levels were measured using an ultra-sensitive
branched DNA amplification assay (Bayer Diagnostics, Berkeley,
CA). Counts of total peripheral blood CD4
+ T lymphocytes and
central memory CD4
+ T lymphocytes were calculated by
multiplying the total lymphocyte count by the percentage of
CD3
+CD4
+ T cells, times the percentage of CD95
+CD28
+ T cells
for counts of central memory CD4
+ T cells, determined by
monoclonal antibody staining and flow cytometric analysis [52].
Extraction of genomic DNA
Total genomic DNA was extracted from peripheral blood
mononuclear cells (PBMCs) or H.papio-immortalized B-lympho-
blastoid cell lines (B-LCLs) using the DNeasy Blood and Tissue Kit
(Qiagen, Valencia, CA). The purity of the isolated genomic DNA
was verified by A260/A280 ratio: average 1.88 (range 1.74–2.00).
The DNA samples were stored at 220uC until use. DNA integrity
was verified by gel-electrophoresis of selected samples.
Determination of KIR3DH copy numbers using real-time
PCR
Activating KIR copy number determinations were performed
by quantitative real-time PCR (qPCR) using the 7300 Real-time
PCR System (Applied Biosystems, Foster City, CA). With
KIR3DH being the only activating KIR receptor family in rhesus
monkeys, a KIR3DH primer and TaqMan probe set for qPCR was
designed to specifically amplify previously identified Mm-KIR3DH
alleles (GenBank accession numbers MmKIR3DH1-4 (AF334648-
AF334651), MmKIR3DH7-21 (EU702453-EU702473), and
MmKIR3DH-like1-4 (AY505479-82)) [17,18], thereby avoiding
recognition of any inhibitory KIR genes. KIR3DH-specific primer
sequences were: Forward: 59-CACCAGACACCTGCCTATTG-
TGA-39; Reverse: 59-GAGTCTCTTTTTGTCGGAGCACCA-
39; Probe: 59-FAM-TAGGTACTCGGTGGCCACCATCAT-
BHQ-39. qPCR products were sequenced to confirm the spe-
cificity of the amplification. The STAT6 gene, present in a single
copy per haploid rhesus genome [22], was used as an endogenous
reference gene: Forward: 59-AACCTAAAGAGAATGGGAG-
TGT-39; Reverse: 59-GAATATAGTCACAACCCTGGATC-39;
Probe: 59-FAM-CTCTGCCCTTCTCCTGCCTCCC-BHQ-39.
Primers were purchased from Invitrogen and probes were
purchased from Biosearch Technologies. Per qPCR reaction,
12.5 ng of total genomic DNA were added to TaqMan Universal
PCR Master Mix (Applied Biosystems) and the specific primers
and probe. All samples were run in triplicate. Thermal cycling
conditions were as follows: 2 min at 50uC, 10 min at 95uC,
followed by 40 cycles of a two-step PCR of 15 s at 95uC and 1 min
at 60uC. qPCR results were analyzed using the SDS v1.4.0
software (Applied Biosystems).
Absolute quantification of KIR3DH copy numbers using
plasmid standard
To determine absolute KIR3DH copy numbers, plasmid DNA
standards for KIR3DH and STAT6 were created. The plasmids
contained the specific sequence amplified in the qPCR reaction.
KIR3DH standard primers were: Forward 59-GGAGGAACCTA-
CAGATGCTTCG-39; Reverse: 59-TCAGAGTCTCTTTTTG-
TCGGAGCAC-39. STAT6 standard primers were: Forward: 59-
CCTTGTCCAAACTGAGTCCAACTGC-39; Reverse: 59-CA-
GACCCAGGACCTCAGACTTC-39.
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rhesus PBMCs using an oligo(dT)20 primer and the SuperScript III
First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad,
CA), following the manufacturer’s protocol. Then, PCR was
performed using the Platinum PCR SuperMix High Fidelity
(Invitrogen). Amplification conditions were: 5min at 94uC; 35
cycles of 30 s at 94uC, 30 s at 55uC, and 45 s at 68uC; and 20 min
at 68uC. PCR products were resolved by gel electrophoresis,
excised and purified with the QIAquick Gel Extraction Kit
(Qiagen). Purified PCR products were ligated into the pGEM-T
Easy Vector (Promega, Madison, WI), resulting in pKIR3DH and
pSTAT6. Clones containing the correct insert were verified
by sequencing. Plasmids were isolated and purified using the
EndoFree Plasmid Maxi Kit (Qiagen), and the plasmid DNA
concentration was measured using a NanoDrop ND-1000
spectrophotometer (Thermo Scientific, Wilmington, DE). Six
serial log dilutions (10
8 –1 0
3 copies) of pKIR3DH and pSTAT6
plasmid DNA were used to generate standard curves by plotting
CT values versus log copies of each qPCR plate. An R
2 value of a
standard curve of less than 99% was considered imprecise and the
corresponding qPCR plate (96 wells) of DNA samples was
repeated. Absolute copy numbers were calculated by determining
the number of KIR3DH copies per sample from the standard curve
and then by normalizing against the number of STAT6 copies in
the same sample. Values were multiplied by 2 to obtain copy
numbers per diploid genome.
Confirmation of qPCR KIR3DH copy number estimates
To validate that the KIR3DH absolute copy numbers calculated
from qPCR were accurate, we determined KIR3DH copy numbers
using a multiplex ligation-dependent probe amplification assay
(MLPA). Two adjacent oligonucleotides per locus – one set for the
KIR3DH loci and, as reference loci, two sets for EP300 (E1A
binding protein p300) and one set for CREBBP (CREB-binding
protein) – were designed to contain the same primer binding
sequences for later amplification. Only one KIR3DH MLPA
oligonucleotide set, recognizing the same KIR3DH alleles as in the
qPCR assay, could be designed due to the polymorphic nature of
the KIR3DH loci. The oligonucleotide sequences are listed in the
Supplementary Table S1 in Text S1 and were purchased from
IDT (IDT, Coralville, IA). All MLPA reagents were purchased
from MRC Holland (MRC-Holland, Amsterdam, Netherlands).
The MLPA reaction was carried out according to the manufac-
turer’s protocol using 100 ng of genomic DNA. For each DNA
sample, the oligonucleotide sets for the KIR3DH genes and the
reference loci were ligated to the DNA in a multiplex PCR and
only ligated oligonucleotides were amplified using the FAM-
labeled universal primer pair. Amplified PCR products differed in
length and could therefore be distinguished. The amplification
products were analyzed on an ABI 3130XL capillary DNA
analyzer (Applied Biosystems). The results were analyzed using
GeneMapper Software (Applied Biosystems). The final analysis of
the MLPA data was carried out using Microsoft Excel software.
For each sample, peak signal values for KIR3DH were normalized
by the average signal of the reference probes to determine relative
MLPA signals [53]. Relative MLPA signals from two different
experiments using the same DNA samples formed discrete clusters
corresponding to copy numbers. Absolute copy numbers of
individual clusters were determined by assuming that the distance
between successive clusters corresponded to 1 copy and that the
copy number genotype of the first cluster corresponded to the
distance from 0 divided by the average distance of successive
clusters.
RNA isolation
PBMCs were sorted for CD14
–CD16
+ NK cells using magnetic
cell sorting (MACS Microbeads by Miltenyi Biotec). Total RNA
was isolated from the CD14
–CD16
+ NK cells using the RNeasy
Mini Kit (Qiagen). RNA samples were stored at 280uC until use.
Quantification of KIR3DH RNA expression
KIR3DH RNA expression in CD14
–CD16
+ NK cells was
determined by performing real-time quantitative reverse tran-
scription PCR (qRT-PCR) using the same KIR3DH and STAT6
primers and probes used for copy number determination of DNA.
Per qRT-PCR reaction, 50 ng of total RNA was added to the
Taqman One-Step RT-PCR Master Mix (Applied Biosystems) and
the KIR3DH- and STAT6-specific primers and probes. All samples
were run in triplicates. Thermal cycling conditions were as follows:
30 min at 48uC, 10 min at 95uC, followed by 40 cycles of a two-
step PCR of 15 s at 95uC and 1 min at 60uC. qRT-PCR results
were analyzed using the SDS v1.4.0 software (Applied Biosystems).
Relative RNA expression was determined using the 2
2DDCt
method (Applied Biosystems). Briefly, for each sample, CT values
of KIR3DH were first normalized against the CT values of STAT6.
Normalized KIR3DH CT values for each monkey were then
divided by the normalized KIR3DH CT values of one reference
monkey that was evaluated in each qPCR run to determine
relative KIR3DH RNA expression.
Discrimination of KIR3DH alleles
Total RNA, isolated from rhesus CD14
–CD16
+ NK cells, was
used to synthesize first-strand cDNA using an oligo(dT)20 primer
and the SuperScript III First-Strand Synthesis System for RT-
PCR (Invitrogen), following the manufacturer’s protocol. PCR
amplification was performed using the Platinum PCR SuperMix
High Fidelity (Invitrogen). The primer sequences were as
described by Blokhuis et al. [18]. Amplification conditions were
as follows: 5 min at 94uC; 35 cycles of 30 s at 94uC, 30 s at 66uC,
and 90 s at 68uC; and 20 min at 68uC. PCR products were
subjected to gel electrophoresis, excised and purified with a
QIAquick Gel Extraction Kit (Qiagen) following the manufactur-
er’s protocol. Purified PCR products were ligated into the pGEM-
T Easy vector (Promega), according to the manufacturer’s
instructions. Briefly, ligation reactions were incubated at room
temperature for one hour and then transformed into JM109 High
Efficiency competent cells (Promega). Between 23 and 28 insert-
containing colonies per sample were sequenced and analyzed
using the Sequencher Software (Gene Codes, Ann Arbor, MI).
Corresponding amino acid sequences were aligned using Clus-
talW2 Multiple Sequence Alignment [54]. Only KIR sequences
that were obtained from more than one clone are reported. The
novel rhesus monkey KIR cDNA sequences have been assigned
the GenBank accession numbers JN613291-JN613300.
Monoclonal antibodies (MAbs) and immunophenotyping
of NK cells
The antibodies used in this study were anti-CD8a-Peridinium
Chlorophyll Protein-Cy5.5 (SK1), anti-CD56-Phycoerythrin-Cy7
(N901, Beckman Coulter, Brea, CA), anti-CD3-Pacific Blue
(SP34.2), anti-CD159 (NKG2A)-Allophycocyanin (Z199, Beckman
Coulter), anti-CD16-Allophycocyanin-Cy7 (3G8), anti-TNFa-Fluo-
rescein Isothiocyanate (MAb11), anti-IFNc-Alexa Fluor 700 (B27)
anti-CD335 (NKp46)-Phycoerythrin (BAB281, Beckman Coulter),
anti-CD69-energy-coupled dye (TP1.55.3, Beckman Coulter), anti-
HLA-DR-Phycoerythrin-Cy7 (L243 (G46-6), anti-Ki67-Alexa Fluor
488 (B56), and anti-CD56-Peridinium Chlorophyll Protein-Cy5.5
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from BD Biosciences. The LIVE/DEAD Fixable Aqua Dead Cell
stain kit (Invitrogen) was used as a viability marker to distinguish live
cells from dead cells in all flow cytometric analyses. All acquisitions
were made on a LSR II flow cytometer (BD Biosciences) and
analyzed using FlowJo software (TreeStar Inc., Ashland, OR).
PBMCs were isolated from EDTA-anticoagulated blood by Ficoll-
Paque (GE Healthcare, Piscataway, NJ) gradient separation and
either stained immediately or cryopreserved in the vapor phase of
liquid nitrogen. Later, cryopreserved cells were thawed and rested at
37uC ina 5%CO2 environment for 6 hrs. The viability of these cells
was . 90%. PBMCs were stained with anti-surface MAbs to
delineate NK cells (CD3, CD8, NKG2A, CD56, and CD16) and
anti-surface molecules CD69, HLA-DR and NKp46. Cells were
then fixed and permeabilized with Cytofix/Cytoperm solution (BD
Biosciences) and stained with antibodies specific for Ki67. Labeled
cells were fixed in 1% formaldehyde-PBS.
PBMC stimulation and intracellular cytokine staining
To determine cytokine production of NK cells in response to
K562 cells, PBMC were incubated for 6 hours in the presence of
RPMI 1640/10% fetal calf serum alone (unstimulated), with K562
at an effector-to-target ratio of 10:1, or with phorbol myristate
acetate (PMA) as a positive control. All samples contained
Monensin (GolgiStop, BD Biosciences) and Brefeldin (Golgi Plug,
BD Biosciences). Cells were next stained with antibodies specific
for cell surface molecules CD3, CD8, NKG2A, CD56, and CD16.
Cells were then fixed and permeabilized with Cytofix/Cytoperm
solution (BD Biosciences) and stained with antibodies specific for
TNFa and IFNc. Labeled cells were fixed in 1% formaldehyde-
PBS. All data are reported after background correction.
Statistical analyses
All statistical analyses and graphic analyses were conducted
using GraphPad Prism (GraphPad Prism Software, La Jolla, CA)
and STATA (StataCorp LP, College Station, Texas). Normality
was assessed using the skewness test, the kurtosis test, the chi-
squared-test and the Shapiro-Wilks-test. The non-parametric
Mann-Whitney-test was used for the comparison of two groups
and the Kruskal-Wallis test was used for comparing more than two
groups. Linear regression models were done for the relationship of
peak viral load and KIR3DH copy number either overall (and
incorporating covariates for Mamu-A*01 and TRIM5 groupings) or
in subgroups. Subsequently, two other regression models (para-
bolic, i.e. second degree polynomial, and two linear splines with a
fixed knot at 5) were used because of previous reports that an
individual NK cell usually expressed at most 5 KIRs [32]. All P
values are two-sided and none are corrected for multiple
comparisons. P values of ,0.05 were considered significant.
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